Acasti Pharma Inc. Gains 18%
Wed, May 19, 2021 at 05:33 PM
Acasti Pharma Inc. (ACST:NASDAQ) shot up at $0.54, representing a gain of 18%. The stock got featured on our News Catalysts scanner on Mon, May 17, 2021 at 09:05 AM in the 'MISCELLANEOUS' category. From Tue, May 04, 2021, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Fri, May 07, 2021 at $0.62 with a volume of 96M+, and its share price has been moving sideways in recent weeks.
About Acasti Pharma Inc. (ACST:NASDAQ)
Acasti Pharma Inc is a biopharmaceutical company. The Company is engaged in the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of cardiometabolic disorders.
Top 10 Gainers:
- MoSys, Inc. (MOSY:NASDAQ), 44.06%
- Lianluo Smart Limited (LLIT:NASDAQ), 24.59%
- Reata Pharmaceuticals, Inc. (RETA:NASDAQ), 23.78%
- VERA (VERA:NASDAQ), 23.56%
- Advaxis, Inc. (ADXS:NASDAQ), 18.65%
- Acasti Pharma Inc. (ACST:NASDAQ), 18%
- Transcat, Inc. (TRNS:NASDAQ), 17.95%
- Home Federal Bancorp, Inc. of Louisiana (HFBL:NASDAQ), 17.92%
- HyreCar Inc. (HYRE:NASDAQ), 17.61%
- LFMD (LFMD:NASDAQ), 16.59%